Cargando…
Treatment of menopausal symptoms with three low-dose continuous sequential 17β-estradiol/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology
Objective: To analyze the short-term efficacy and safety over menopausal symptoms of three low-dose continuous sequential 17β-estradiol (E)/progesterone (P) parental monthly formulations using novel non-polymeric microspheres. Methods: This was a multicenter, randomized, single blinded study in whic...
Autores principales: | Cortés-Bonilla, Manuel, Bernardo-Escudero, Roberto, Alonso-Campero, Rosalba, Francisco-Doce, María T., Hernández-Valencia, Marcelino, Celis-González, Cuauhtémoc, Márquez-Oñate, Ricardo, Chedraui, Peter, Uribe, Juan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776687/ https://www.ncbi.nlm.nih.gov/pubmed/26062108 http://dx.doi.org/10.3109/09513590.2015.1019853 |
Ejemplares similares
-
Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy
por: Pickar, James H., et al.
Publicado: (2015) -
Sarcopenia and Menopause: The Role of Estradiol
por: Geraci, Annalisa, et al.
Publicado: (2021) -
Breast effects of oral, combined 17β-estradiol, and progesterone capsules in menopausal women: a randomized controlled trial
por: Liu, James H., et al.
Publicado: (2020) -
Vitamin D supplementation after the menopause
por: Pérez-López, Faustino R., et al.
Publicado: (2020) -
Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes
por: Mauvais-Jarvis, Franck, et al.
Publicado: (2020)